Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXCARBAZEPINE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where OXCARBAZEPINE was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for OXCARBAZEPINE

Side Effect Reports % Deaths Hosp.
Seizure 1,525 14.1% 57 367
Drug ineffective 1,498 13.9% 25 365
Off label use 751 7.0% 45 291
Hyponatraemia 708 6.6% 10 367
Somnolence 634 5.9% 6 174
Dizziness 558 5.2% 7 199
Fatigue 551 5.1% 6 113
Epilepsy 509 4.7% 15 146
Headache 505 4.7% 3 145
Asthenia 429 4.0% 3 131
Rash 408 3.8% 26 167
Balance disorder 402 3.7% 1 150
Toxicity to various agents 361 3.3% 160 260
Anxiety 360 3.3% 8 63
Fall 355 3.3% 7 224

Other Indications for OXCARBAZEPINE

Product used for unknown indication (3,322) Epilepsy (2,088) Seizure (1,160) Partial seizures (474) Trigeminal neuralgia (360) Bipolar disorder (228) Generalised tonic-clonic seizure (167) Status epilepticus (140) Affective disorder (112) Neuralgia (84)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

OXCARBAZEPINE Full Profile All Relapsing-remitting multiple sclerosis Drugs OXCARBAZEPINE Demographics OXCARBAZEPINE Timeline